Benefit/risk ratio of statins in primary prevention.
Reidenberg
M M
MM
Department of Pharmacology, Weill Cornell Medical College, New York, New York, USA. mmreid@med.cornell.edu
D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D016017:Odds Ratio; D011322:Primary Prevention / Q000379:methods; D018570:Risk Assessment
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors